Ipca Laboratories issues revised link for Q4FY26 call

0 min read Updated on 02 Jun 2026, 06:26 AM

Reviewed by

Suketu GScanX News Team

AI Summary

Ipca Laboratories has issued a revised passcode link for its Q4FY26 earnings conference call and business update scheduled for June 1, 2026, at 15:30 hrs IST. The disclosure was made to BSE Ltd. and National Stock Exchange India Limited under Regulation 30 by Harish P. Kamath, Corporate Counsel & Company Secretary.

*this image is generated using AI for illustrative purposes only.

Ipca Laboratories has issued a revised passcode link for its Q4FY26 earnings conference call and business update scheduled for June 1, 2026. The session is set to begin at 15:30 hrs IST, providing stakeholders with a detailed review of the company's financial performance for the fourth quarter.

The disclosure regarding the revised access link was submitted to BSE Ltd. and National Stock Exchange India Limited under Regulation 30. Harish P. Kamath, Corporate Counsel & Company Secretary, signed the communication. The registered office of Ipca Laboratories is located at the Kandivli Industrial Estate in Mumbai.

Conference Call Details

The table below summarizes the key particulars of the event:

Event	Date	Time (IST)
Q4FY26 Earnings Conference Call	June 1, 2026	15:30 hrs

Historical Stock Returns for IPCA Laboratories

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-1.90%	-1.92%	+3.13%	+7.55%	+13.93%	+54.68%

What are the key financial metrics analysts expect Ipca Laboratories to report for Q4FY26?

How might the company's performance in Q4FY26 impact its stock price in the short term?

What strategic initiatives or business updates is Ipca Laboratories likely to discuss during the call?

Conference Call Details

The earnings call will be held on Monday, June 1, 2026, from 15:30 hrs to 16:30 hrs IST. This session follows the announcement of the company's Q4FY26 financial results on Friday, May 29, 2026. The discussion will focus on the quarterly earnings and provide a broader business update.

Management Representation

The leadership team representing Ipca Laboratories during the call will include key executives responsible for steering the company's operations. The panel features:

Mr. A K Jain – Managing Director
Mr. Harish Kamath – Corporate Counsel & Company Secretary

Access Information

Dam Capital Advisors Ltd. will host the conference call. Participants can join the discussion using the universal access numbers provided below. The company recommends dialing in at least 5 to 10 minutes prior to the scheduled start time to ensure a timely connection.


Universal Access:	+91-22- 6280 1384
	+91-22- 7115 8285

These lines are accessible from all networks and countries. For those requiring further information or assistance regarding the event, contact details for the company and the advisory firm have been made available.

Historical Stock Returns for IPCA Laboratories

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-1.90%	-1.92%	+3.13%	+7.55%	+13.93%	+54.68%

How might Ipca Laboratories' Q4FY26 results reflect the impact of recent USFDA regulatory developments on its export-driven revenue segments?

What guidance is management likely to provide regarding the integration and performance of Unichem Laboratories following its acquisition?

How could Ipca Laboratories' API and formulations business outlook be affected by evolving global supply chain dynamics and China+1 sourcing strategies?